Triglyceride-glucose index and obstructive sleep apnea: a systematic review and meta-analysis.
Meta-analysis
Obstructive sleep apnea
Systematic review
Triglyceride-glucose index
TyG
Journal
Lipids in health and disease
ISSN: 1476-511X
Titre abrégé: Lipids Health Dis
Pays: England
ID NLM: 101147696
Informations de publication
Date de publication:
08 Jan 2024
08 Jan 2024
Historique:
received:
25
10
2023
accepted:
01
01
2024
medline:
8
1
2024
pubmed:
8
1
2024
entrez:
7
1
2024
Statut:
epublish
Résumé
Obstructive sleep apnea (OSA) has a bidirectional association with metabolic syndrome, and insulin resistance (IR). The triglyceride-glucose (TyG) index could be a simply calculated marker of IR in OSA. However, its clinical application appears still limited. Hence, this systematic review and meta-analysis aimed to respond to this question by analyzing all the existing studies showing an association between OSA and the TyG index. Four online databases, including PubMed, Scopus, the Web of Science, and Embase were searched for studies evaluating the TyG index in OSA. After screening and data extraction, a random-effect meta-analysis was performed to compare the TyG index in OSA patients vs. healthy controls by calculating standardized mean difference (SMD) and 95% confidence interval (CI) and pooling the area under the curves (AUCs) for diagnosis of OSA based on this index. Ten studies involving 16,726 individuals were included in the current systematic review. Meta-analysis indicated that there was a significantly higher TyG index in patients with OSA, compared with the healthy controls (SMD 0.856, 95% CI 0.579 to 1.132, P < 0.001). Also, TyG had a diagnostic ability for OSA representing a pooled AUC of 0.681 (95% CI 0.627 to 0.735). However, based on the two studies' findings, no difference between different severities of OSA was observed. Finally, our data showed that the TyG index is a good potential predictor of adverse outcomes in these patients. Our study revealed that the TyG index is an easy-to-measure marker of IR for assessing OSA, both in diagnosis and prognosis. Our study supports its implementation in routine practice to help clinicians in decision-making and patient stratification.
Sections du résumé
BACKGROUND
BACKGROUND
Obstructive sleep apnea (OSA) has a bidirectional association with metabolic syndrome, and insulin resistance (IR). The triglyceride-glucose (TyG) index could be a simply calculated marker of IR in OSA. However, its clinical application appears still limited. Hence, this systematic review and meta-analysis aimed to respond to this question by analyzing all the existing studies showing an association between OSA and the TyG index.
METHODS
METHODS
Four online databases, including PubMed, Scopus, the Web of Science, and Embase were searched for studies evaluating the TyG index in OSA. After screening and data extraction, a random-effect meta-analysis was performed to compare the TyG index in OSA patients vs. healthy controls by calculating standardized mean difference (SMD) and 95% confidence interval (CI) and pooling the area under the curves (AUCs) for diagnosis of OSA based on this index.
RESULTS
RESULTS
Ten studies involving 16,726 individuals were included in the current systematic review. Meta-analysis indicated that there was a significantly higher TyG index in patients with OSA, compared with the healthy controls (SMD 0.856, 95% CI 0.579 to 1.132, P < 0.001). Also, TyG had a diagnostic ability for OSA representing a pooled AUC of 0.681 (95% CI 0.627 to 0.735). However, based on the two studies' findings, no difference between different severities of OSA was observed. Finally, our data showed that the TyG index is a good potential predictor of adverse outcomes in these patients.
CONCLUSION
CONCLUSIONS
Our study revealed that the TyG index is an easy-to-measure marker of IR for assessing OSA, both in diagnosis and prognosis. Our study supports its implementation in routine practice to help clinicians in decision-making and patient stratification.
Identifiants
pubmed: 38185682
doi: 10.1186/s12944-024-02005-3
pii: 10.1186/s12944-024-02005-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4Informations de copyright
© 2024. The Author(s).
Références
Lévy P, Kohler M, McNicholas WT, Barbé F, McEvoy RD, Somers VK, et al. Obstructive sleep apnoea syndrome. Nat Rev Dis Primers. 2015;1:15015.
pubmed: 27188535
WHO. Global surveillance, prevention and control of chronic respiratory diseases. 2007.
Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019;7(8):687–98.
pubmed: 31300334
pmcid: 7007763
Ge X, Han F, Huang Y, Zhang Y, Yang T, Bai C, et al. Is obstructive sleep apnea associated with cardiovascular and all-cause mortality? PLoS ONE. 2013;8(7):e69432.
pubmed: 23936014
pmcid: 3723897
Michalek-Zrabkowska M, Macek P, Martynowicz H, Gac P, Mazur G, Grzeda M et al. Obstructive sleep apnea as a risk factor of insulin resistance in nondiabetic adults. Life (Basel). 2021;11(1).
Yacoub M, Youssef I, Salifu MO, McFarlane SI. Cardiovascular Disease Risk in Obstructive Sleep apnea: an update. J Sleep Disord Ther. 2017;7(1).
Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest. 2007;131(5):1387–92.
pubmed: 17494788
McArdle N, Hillman D, Beilin L, Watts G. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med. 2007;175(2):190–5.
pubmed: 17068329
Kent BD, McNicholas WT, Ryan S. Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea. J Thorac Dis. 2015;7(8):1343–57.
pubmed: 26380761
pmcid: 4561252
Lam JC, Mak JC, Ip MS. Obesity, obstructive sleep apnoea and metabolic syndrome. Respirology. 2012;17(2):223–36.
pubmed: 21992649
Drager LF, Togeiro SM, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol. 2013;62(7):569–76.
pubmed: 23770180
pmcid: 4461232
Kent BD, Grote L, Ryan S, Pépin JL, Bonsignore MR, Tkacova R, et al. Diabetes mellitus prevalence and control in sleep-disordered breathing: the European Sleep Apnea Cohort (ESADA) study. Chest. 2014;146(4):982–90.
pubmed: 24831859
Huang T, Sands SA, Stampfer MJ, Tworoger SS, Hu FB, Redline S. Insulin resistance, hyperglycemia, and risk of developing obstructive sleep apnea in men and women in the United States. Ann Am Thorac Soc. 2022;19(10):1740–9.
pubmed: 35385367
pmcid: 9528746
n den Borst B, Gosker HR, Zeegers MP, Schols AM. Pulmonary function in diabetes: a metaanalysis. Chest. 2010;138(2):393–406.
pubmed: 20348195
Lecube A, Simó R, Pallayova M, Punjabi NM, López-Cano C, Turino C, et al. Pulmonary function and sleep breathing: two new targets for type 2 Diabetes Care. Endocr Rev. 2017;38(6):550–73.
pubmed: 28938479
Llanos OL, Galiatsatos P, Guzmán-Vélez E, Patil SP, Smith PL, Magnuson T, et al. Pharyngeal collapsibility during sleep is elevated in insulin-resistant females with morbid obesity. Eur Respir J. 2016;47(6):1718–26.
pubmed: 27103392
pmcid: 5937533
Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008;294(1):E15–26.
pubmed: 17957034
Bikov A, Frent SM, Meszaros M, Kunos L, Mathioudakis AG, Negru AG et al. Triglyceride-glucose index in Non-Diabetic, non-obese patients with obstructive sleep apnoea. J Clin Med. 2021;10(9).
Khalaji A, Behnoush AH, Khanmohammadi S, Ghanbari Mardasi K, Sharifkashani S, Sahebkar A, et al. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):244.
pubmed: 37679763
pmcid: 10486123
Pei H, Li S, Su X, Lu Y, Wang Z, Wu S. Association between triglyceride glucose index and sleep disorders: results from the NHANES 2005–2008. BMC Psychiatry. 2023;23(1):156.
pubmed: 36899383
pmcid: 10007799
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
pubmed: 20652370
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evid Based Ment Health. 2019;22(4):153–60.
pubmed: 31563865
pmcid: 10231495
Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser a Stat Soc. 2009;172(1):137–59.
pubmed: 19381330
pmcid: 2667312
Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29–36.
pubmed: 7063747
Obuchowski NA, Lieber ML, Wians FH. Jr. ROC curves in clinical chemistry: uses, misuses, and possible solutions. Clin Chem. 2004;50(7):1118–25.
pubmed: 15142978
Hedges LV. Distribution theory for Glass’s estimator of Effect size and related estimators. J Educational Stat. 1981;6(2):107–28.
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805.
pubmed: 27683581
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.
pubmed: 25524443
pmcid: 4383202
Bianchi VE, Herbert WG, Myers J, Ribisl PM, Miller LE, Dalman RL. Relationship of obstructive sleep apnea and cardiometabolic risk factors in elderly patients with abdominal aortic aneurysm. Sleep Breath. 2015;19(2):593–8.
pubmed: 25204854
Hu J, Cai X, Li N, Zhu Q, Wen W, Hong J, et al. Association between triglyceride glucose Index-Waist circumference and risk of first myocardial infarction in Chinese hypertensive patients with obstructive sleep apnoea: an Observational Cohort Study. Nat Sci Sleep. 2022;14:969–80.
pubmed: 35615442
pmcid: 9126228
Jiang R, Li Y. Value of triglyceride - glucose index combined with obesity index in predicting nonalcoholic fatty liver disease in individuals with obstructive sleep apnea. J Clin Hepatol. 2023;39(3):546–51.
Kang HH, Kim SW, Lee SH. Association between triglyceride glucose index and obstructive sleep apnea risk in Korean adults: a cross-sectional cohort study. Lipids Health Dis. 2020;19(1):182.
pubmed: 32771021
pmcid: 7414547
Meszaros M, Kunos L, Tarnoki AD, Tarnoki DL, Lazar Z, Bikov A. The role of Soluble Low-Density Lipoprotein receptor-related Protein-1 in obstructive sleep apnoea. J Clin Med. 2021;10(7).
Pan QY, Li HQ, Gan XY, Chen X, Liu XR, Li JF. Relationship between slow-wave sleep and serum gamma-glutamine transaminase in non-obese men with obstructive sleep apnea-hypopnea syndrome. Sleep Breath. 2022.
Wei RB, Gao ZF, Xu HJ, Jiang CP, Li XY, Liu YP, et al. Body Fat Indices as effective predictors of insulin resistance in Obstructive Sleep Apnea: evidence from a cross-sectional and longitudinal study BFI as predictors of IR in OSA. Obes Surg. 2021;31(5):2219–30.
pubmed: 33569729
Zou J, Wang Y, Xu H, Xia Y, Qian Y, Zou J, et al. The use of visceral adiposity variables in the prediction of obstructive sleep apnea: evidence from a large cross-sectional study. Sleep Breath. 2020;24(4):1373–82.
pubmed: 31832983
Sharma SK, Vasudev C, Sinha S, Banga A, Pandey RM, Handa KK. Validation of the modified Berlin questionnaire to identify patients at risk for the obstructive sleep apnoea syndrome. Indian J Med Res. 2006;124(3):281–90.
pubmed: 17085831
Bikov A, Meszaros M, Kunos L, Negru AG, Frent SM, Mihaicuta S. Atherogenic Index of Plasma in obstructive sleep apnoea. J Clin Med. 2021;10(3).
Dong L, Lin M, Wang W, Ma D, Chen Y, Su W, et al. Lipid accumulation product (LAP) was independently associatedwith obstructive sleep apnea in patients with type 2 diabetes mellitus. BMC Endocr Disord. 2020;20(1):179.
pubmed: 33298050
pmcid: 7727244
Lin HJ, Chen PC, Liu YH, Hsu CY. Increasing and high prevalence of moderate to severe obstructive sleep apnea in acute ischemic stroke in Taiwan. J Formos Med Assoc. 2023.
Ercolano E, Bencivenga L, Palaia ME, Carbone G, Scognamiglio F, Rengo G et al. Intricate relationship between obstructive sleep apnea and dementia in older adults. Geroscience. 2023.
Sanchez-Azofra A, Gu W, Masso-Silva JA, Sanz-Rubio D, Marin-Oto M, Cubero P, et al. Inflammation biomarkers in OSA, chronic obstructive pulmonary disease, and chronic obstructive pulmonary disease/OSA overlap syndrome. J Clin Sleep Med. 2023;19(8):1447–56.
pubmed: 37082823
Atkeson A, Yeh SY, Malhotra A, Jelic S. Endothelial function in obstructive sleep apnea. Prog Cardiovasc Dis. 2009;51(5):351–62.
pubmed: 19249441
pmcid: 4329644
Behnoush AH, Khalaji A, Amirkhani N, Pezeshki PS. Diagnostic role of circulating endocan levels in obstructive sleep apnea: a systematic review and Meta-analysis. Angiology. 2023:33197231183087.
Chuang LP, Lin SW, Lee LA, Chang CH, Huang HY, Hu HC, et al. Elevated Serum Markers of Acute Kidney Injury in patients with obstructive sleep apnea. J Clin Sleep Med. 2019;15(2):207–13.
pubmed: 30736871
pmcid: 6374082
Khalaji A, Amirkhani N, Sharifkashani S, Behnoush AH. Role of galectin-3 as a biomarker in obstructive sleep apnea: a systematic review and meta-analysis. Sleep Breath. 2023;27(6):2273–82.
pubmed: 37129844
Luo P, Cao Y, Li P, Li W, Song Z, Fu Z et al. TyG Index performs Better Than HOMA-IR in Chinese type 2 diabetes Mellitus with a BMI < 35 kg/m2: a hyperglycemic clamp validated study. Med (Kaunas). 2022;58(7).
Son DH, Lee HS, Lee YJ, Lee JH, Han JH. Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutr Metab Cardiovasc Dis. 2022;32(3):596–604.
pubmed: 35090800
Wan Y, Zhang Z, Ling Y, Cui H, Tao Z, Pei J, et al. Association of triglyceride-glucose index with cardiovascular disease among a general population: a prospective cohort study. Diabetol Metab Syndr. 2023;15(1):204.
pubmed: 37845738
pmcid: 10580532
Hong S, Han K, Park CY. The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimers Res Ther. 2021;13(1):9.
pubmed: 33402193
pmcid: 7786939
Lindberg E, Theorell-Haglöw J, Svensson M, Gislason T, Berne C, Janson C. Sleep apnea and glucose metabolism: a long-term follow-up in a community-based sample. Chest. 2012;142(4):935–42.
pubmed: 22499826
Mesarwi O, Polak J, Jun J, Polotsky VY. Sleep disorders and the development of insulin resistance and obesity. Endocrinol Metab Clin North Am. 2013;42(3):617–34.
pubmed: 24011890
pmcid: 3767932
Gabryelska A, Szmyd B, Panek M, Szemraj J, Kuna P, Białasiewicz P. Serum hypoxia-inducible factor-1α protein level as a diagnostic marker of obstructive sleep apnea. Pol Arch Intern Med. 2020;130(2):158–60.
pubmed: 31834288
Cheng Y, Fang Z, Zhang X, Wen Y, Lu J, He S, et al. Association between triglyceride glucose-body mass index and cardiovascular outcomes in patients undergoing percutaneous coronary intervention: a retrospective study. Cardiovasc Diabetol. 2023;22(1):75.
pubmed: 36997935
pmcid: 10064664
Tramunt B, Smati S, Grandgeorge N, Lenfant F, Arnal JF, Montagner A, et al. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia. 2020;63(3):453–61.
pubmed: 31754750
Wang Y, Mao L, Zhang X. Waist-hip ratio is an independent predictor of moderate-to-severe OSA in nonobese males: a cross-sectional study. BMC Pulm Med. 2022;22(1):151.
pubmed: 35459124
pmcid: 9034636
Lim YH, Choi J, Kim KR, Shin J, Hwang KG, Ryu S, et al. Sex-specific characteristics of anthropometry in patients with obstructive sleep apnea: neck circumference and waist-hip ratio. Ann Otol Rhinol Laryngol. 2014;123(7):517–23.
pubmed: 24668052
Kum RO, Kundi FCS, Baklacı D, Kum NY, Güler İ, Yılmaz YF, et al. Predicting severe sleep apnea in patients with complaints: Pulse Oximetry and Body Mass Index. Turk Arch Otorhinolaryngol. 2018;56(3):149–54.
pubmed: 30319871
pmcid: 6177497
Behnoush AH, Bahiraie P, Shokri Varniab Z, Foroutani L, Khalaji A. Composite lipid indices in patients with obstructive sleep apnea: a systematic review and meta-analysis. Lipids Health Dis. 2023;22(1):84.
pubmed: 37386562
pmcid: 10308736
Drager LF, Lopes HF, Maki-Nunes C, Trombetta IC, Toschi-Dias E, Alves MJ, et al. The impact of obstructive sleep apnea on metabolic and inflammatory markers in consecutive patients with metabolic syndrome. PLoS ONE. 2010;5(8):e12065.
pubmed: 20711453
pmcid: 2920316
Meszaros M, Tarnoki AD, Tarnoki DL, Kovacs DT, Forgo B, Lee J, et al. Obstructive sleep apnea and hypertriglyceridaemia share common genetic background: results of a twin study. J Sleep Res. 2020;29(4):e12979.
pubmed: 31908118
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
pubmed: 3899825
Li X, Wang J, Niu L, Tan Z, Ma J, He L, et al. Prevalence estimates of the insulin resistance and associated prevalence of heart failure among United Status adults. BMC Cardiovasc Disord. 2023;23(1):294.
pubmed: 37301866
pmcid: 10257843
Kang ES, Yun YS, Park SW, Kim HJ, Ahn CW, Song YD, et al. Limitation of the validity of the homeostasis model assessment as an index of insulin resistance in Korea. Metabolism. 2005;54(2):206–11.
pubmed: 15690315
Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, Yamanaka A, Pareja JC, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100.
pubmed: 21665314
Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6(4):299–304.
pubmed: 19067533
Liu XZ, Fan J, Pan SJ. METS-IR, a novel simple insulin resistance indexes, is associated with hypertension in normal-weight Chinese adults. J Clin Hypertens (Greenwich). 2019;21(8):1075–81.
pubmed: 31282098